Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (DEFICIENCY) (Details 1)

v3.19.1
STOCKHOLDERS' EQUITY (DEFICIENCY) (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Weighted average remaining contractual life, Outstanding - beginning of the year 2 years  
Employee Stock Option [Member]    
Number of options, Outstanding - beginning of the year 1,227,774 1,234,934
Number of options, Granted 338,750
Number of options, Exercised (48,017)
Number of options, Expired or Forfeited (71,920) (7,160)
Number of options, Outstanding - end of the year 1,446,587 1,227,774
Number of options, Exercisable at end of year 1,217,818  
Weighted average exercise price, Outstanding - beginning of the year $ 3.01 $ 3.01
Weighted average exercise price, Granted 4.75
Weighted average exercise price, Exercised 0.07
Weighted average exercise price, Expired or Forfeited 4.41 10.08
Weighted average exercise price, Outstanding - end of the year 3.16 $ 3.01
Weighted average exercise price, Exercisable at end of year $ 3.26  
Weighted average remaining contractual life, Outstanding - beginning of the year 7 years 2 months 5 days 7 years 2 months 5 days
Weighted average remaining contractual life, Granted 9 years 7 months 24 days
Weighted average remaining contractual life, Exercised 4 years 2 months 26 days  
Weighted average remaining contractual life, Expired or Forfeited 7 years 1 month 28 days  
Weighted average remaining contractual life, Outstanding- end of the year 7 years 10 months 13 days 7 years 2 months 5 days
Weighted average remaining contractual life, Exercisable at end of year 7 years 1 month 2 days  
Aggregate intrinsic value, Outstanding - beginning of the year $ 3,419 $ 3,419
Aggregate intrinsic value, Granted 735
Aggregate intrinsic value, Exercised
Aggregate intrinsic value, Expired or Forfeited
Aggregate intrinsic value, Outstanding - end of the year 4,578 $ 3,419
Aggregate intrinsic value, Exercisable at end of year $ 3,969